| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |